Search

everythinglearnresearchcommunity

for

Search:↓

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Dermoscopy is becoming essential for diagnosing skin conditions and is expected to be a standard tool for dermatologists.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The study found no link between vitamin D deficiency and psoriasis but suggests more research is needed.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

The document corrected previous errors and announced future dermatology events.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The timing of when the gene Bmal1 is active affects aging and survival, with its absence during development, not adulthood, leading to premature aging.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Growth factors are crucial for hair development and could help treat hair diseases.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Reflectance confocal microscopy confirms that yellow dots are signs of damaged hair follicles in alopecia areata.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.